Provided By GlobeNewswire
Last update: Dec 5, 2024
BERKELEY HEIGHTS, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative cancer medicines, today announced that it is in the process of exploring and reviewing strategic alternatives on an expedited basis in order to preserve the Company’s cash, including a potential transaction with investor David Lazar of Activist Investing, LLC, which transaction would be subject to the consent of an existing securityholder.
Read more at globenewswire.com0.2512
+0.01 (+2.74%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (5/2/2025, 8:00:01 PM)
3.74
-0.76 (-16.89%)
Find more stocks in the Stock Screener
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Let's have a look at the stocks with an unusual volume in today's session.
Let's have a look at the gap up and gap down stocks in today's session.
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.